Teva Applies Pressure, Purchases Mylan Stock

Bloomberg reported that Teva Pharmaceutical Industries Ltd. bought 1.35 percent of Mylan stock, putting pressure on the company to accept a takeover offer.

“Acquiring shares of Mylan underscores our commitment to consummating a transaction as soon as possible,” Teva said in a statement. Read the Bloomberg article